Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul;69(7):528-535.
doi: 10.1007/s00105-018-4204-8.

[Dermatoscopic-pathological correlation of melanocytic skin lesions]

[Article in German]
Affiliations
Review

[Dermatoscopic-pathological correlation of melanocytic skin lesions]

[Article in German]
H Kittler. Hautarzt. 2018 Jul.

Abstract

There is no doubt that dermatopathology is the most important method to decide if a melanocytic lesion is benign or malignant; however, like most morphologic examinations, dermatopathology is subjective. A recent study demonstrated that the pathologic diagnosis of melanocytic skin lesions has a high variability. Reports with false-positive or false-negative diagnoses are relatively common. The pathologic examination of melanocytic lesions also has observer-independent limitations and one has to accept that some melanocytic lesions cannot be classified as benign or malignant with confidence by dermatopathology alone. If a confident diagnosis is not possible a dermatoscopic-pathologic correlation may be helpful. This, however, is only possible if dermatoscopic images are available and if the dermatopathologist knows how to interpret dermatoscopic structures. A dermatoscopic-pathologic correlation is not useful in all difficult melanocytic lesions but it should be considered in difficult flat pigmented lesions. In these cases dermatoscopy may provide even more important additional information than molecular findings.

Keywords: Dermatooncology; Dermatopathology; Dermoscopy/Dermatoscopy; Melanoma; Nevi.

PubMed Disclaimer

Similar articles

References

    1. Dermatol Clin. 2001 Apr;19(2):259-68, vii - PubMed
    1. Arch Dermatol. 2006 Sep;142(9):1113-9 - PubMed
    1. Am J Dermatopathol. 2012 Oct;34(7):710-5 - PubMed
    1. J Am Acad Dermatol. 2000 Sep;43(3):467-76 - PubMed
    1. J Invest Dermatol. 2017 May;137(5):e57-e59 - PubMed

LinkOut - more resources